Trials / Unknown
UnknownNCT00947102
Influence of Gemcitabine Treatment on Immunological and Serological Profile in Patients With Pancreatic Cancer
Observational Study - Influence of Gemcitabine Treatment on Immunological and Serological Profile in Patients With Pancreatic Tubular Carcinoma
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- —
- Sponsor
- Blood Transfusion Centre of Slovenia · Other Government
- Sex
- All
- Age
- 30 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Observational study of influence of gemcitabine treatment on serological and immunological status and gene expression profile in patients with pancreatic tubular carcinoma after tumor resection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Observation |
Timeline
- Start date
- 2009-02-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2009-07-27
- Last updated
- 2010-01-13
Locations
1 site across 1 country: Slovenia
Source: ClinicalTrials.gov record NCT00947102. Inclusion in this directory is not an endorsement.